Less common effects to keep an eye on Less often, people experience prolonged bruising over one to two weeks, hyperpigmentation (temporary darkening of the treated skin), or, rarely, a localised infection
Compounded products are not FDA-approved and have not been evaluated by the FDA for safety or efficacy
Berwanger, O
Recently, the FDA has approved select GLP-1 therapies specifically for weight loss, including: Wegovy Saxenda Zepbound, a GIP/GLP-1 dual-acting therapy Of course, successful weight loss treatment is incredible news for the 42 percent of Americans who have obesity
Inform them about: Your IBS subtype (constipation, diarrhoea, or mixed) Current symptom severity and frequency Existing IBS treatments and their effectiveness Previous responses to medications affecting gut motility Impact of IBS on your quality of life This information helps clinicians make informed decisions about whether GLP-1 therapy is appropriate and how to monitor you effectively